171 related articles for article (PubMed ID: 36240625)
1. Neonicotinoid insecticides promote breast cancer progression via G protein-coupled estrogen receptor: In vivo, in vitro and in silico studies.
Li X; He S; Xiao H; He TT; Zhang JD; Luo ZR; Ma JZ; Yin YL; Luo L; Cao LY
Environ Int; 2022 Dec; 170():107568. PubMed ID: 36240625
[TBL] [Abstract][Full Text] [Related]
2. Triclocarban and triclosan promote breast cancer progression in vitro and in vivo via activating G protein-coupled estrogen receptor signaling pathways.
He TT; Li X; Ma JZ; Yang Y; Zhu S; Zeng J; Luo L; Yin YL; Cao LY
Sci Total Environ; 2024 Jun; 931():172782. PubMed ID: 38679099
[TBL] [Abstract][Full Text] [Related]
3. Hydroxylated Polybrominated Diphenyl Ethers Exert Estrogenic Effects via Non-Genomic G Protein-Coupled Estrogen Receptor Mediated Pathways.
Cao LY; Ren XM; Yang Y; Wan B; Guo LH; Chen D; Fan Y
Environ Health Perspect; 2018 May; 126(5):057005. PubMed ID: 29790728
[TBL] [Abstract][Full Text] [Related]
4. Bisphenol AF and Bisphenol B Exert Higher Estrogenic Effects than Bisphenol A via G Protein-Coupled Estrogen Receptor Pathway.
Cao LY; Ren XM; Li CH; Zhang J; Qin WP; Yang Y; Wan B; Guo LH
Environ Sci Technol; 2017 Oct; 51(19):11423-11430. PubMed ID: 28858478
[TBL] [Abstract][Full Text] [Related]
5. AHR and GPER mediate the stimulatory effects induced by 3-methylcholanthrene in breast cancer cells and cancer-associated fibroblasts (CAFs).
Cirillo F; Lappano R; Bruno L; Rizzuti B; Grande F; Guzzi R; Briguori S; Miglietta AM; Nakajima M; Di Martino MT; Maggiolini M
J Exp Clin Cancer Res; 2019 Aug; 38(1):335. PubMed ID: 31370872
[TBL] [Abstract][Full Text] [Related]
6. Insight into the mechanism of tetrachlorobisphenol A (TCBPA)-induced proliferation of breast cancer cells by GPER-mediated signaling pathways.
Lei B; Tang Q; Sun S; Zhang X; Huang Y; Xu L
Environ Pollut; 2021 Apr; 275():116636. PubMed ID: 33582643
[TBL] [Abstract][Full Text] [Related]
7. MIBE acts as antagonist ligand of both estrogen receptor α and GPER in breast cancer cells.
Lappano R; Santolla MF; Pupo M; Sinicropi MS; Caruso A; Rosano C; Maggiolini M
Breast Cancer Res; 2012 Jan; 14(1):R12. PubMed ID: 22251451
[TBL] [Abstract][Full Text] [Related]
8. G protein-coupled estrogen receptor regulates mammary tumorigenesis and metastasis.
Marjon NA; Hu C; Hathaway HJ; Prossnitz ER
Mol Cancer Res; 2014 Nov; 12(11):1644-1654. PubMed ID: 25030371
[TBL] [Abstract][Full Text] [Related]
9. Tanshinone IIA Inhibits Triple-Negative Breast Cancer Cells MDA-MB-231 via G Protein-Coupled Estrogen Receptor- (GPER-) Dependent Signaling Pathway.
He Y; Yang K; Liu J; Shi D; Zhang Z; Yang J; Chen M; Zhao P
Dis Markers; 2023; 2023():8371623. PubMed ID: 36741908
[TBL] [Abstract][Full Text] [Related]
10. GPER mediates activation of HIF1α/VEGF signaling by estrogens.
De Francesco EM; Pellegrino M; Santolla MF; Lappano R; Ricchio E; Abonante S; Maggiolini M
Cancer Res; 2014 Aug; 74(15):4053-64. PubMed ID: 24894716
[TBL] [Abstract][Full Text] [Related]
11. Expression and Role of the G Protein-Coupled Estrogen Receptor (GPR30/GPER) in the Development and Immune Response in Female Reproductive Cancers.
Hernández-Silva CD; Villegas-Pineda JC; Pereira-Suárez AL
Front Endocrinol (Lausanne); 2020; 11():544. PubMed ID: 32973677
[TBL] [Abstract][Full Text] [Related]
12. Tricresyl phosphate isomers exert estrogenic effects via G protein-coupled estrogen receptor-mediated pathways.
Ji X; Li N; Ma M; Rao K; Yang R; Wang Z
Environ Pollut; 2020 Sep; 264():114747. PubMed ID: 32559878
[TBL] [Abstract][Full Text] [Related]
13. Dynamic monitoring of GPER-mediated estrogenic effects in breast cancer associated fibroblasts: An alternative role of estrogen in mammary carcinoma development.
Luo H; Liu M; Luo S; Yu T; Wu C; Yang G; Tu G
Steroids; 2016 Aug; 112():1-11. PubMed ID: 27016131
[TBL] [Abstract][Full Text] [Related]
14. GPER mediated estradiol reduces miR-148a to promote HLA-G expression in breast cancer.
Tao S; He H; Chen Q; Yue W
Biochem Biophys Res Commun; 2014 Aug; 451(1):74-8. PubMed ID: 25063027
[TBL] [Abstract][Full Text] [Related]
15. G protein-coupled estrogen receptor (GPER) mediates NSCLC progression induced by 17β-estradiol (E2) and selective agonist G1.
Liu C; Liao Y; Fan S; Tang H; Jiang Z; Zhou B; Xiong J; Zhou S; Zou M; Wang J
Med Oncol; 2015 Apr; 32(4):104. PubMed ID: 25744245
[TBL] [Abstract][Full Text] [Related]
16. Estrogen-mediated inactivation of FOXO3a by the G protein-coupled estrogen receptor GPER.
Zekas E; Prossnitz ER
BMC Cancer; 2015 Oct; 15():702. PubMed ID: 26470790
[TBL] [Abstract][Full Text] [Related]
17. The G Protein-Coupled Estrogen Receptor (GPER) Expression Correlates with Pro-Metastatic Pathways in ER-Negative Breast Cancer: A Bioinformatics Analysis.
Talia M; De Francesco EM; Rigiracciolo DC; Muoio MG; Muglia L; Belfiore A; Maggiolini M; Sims AH; Lappano R
Cells; 2020 Mar; 9(3):. PubMed ID: 32143514
[TBL] [Abstract][Full Text] [Related]
18. Bisphenol A increases the size of primary mammary tumors and promotes metastasis in a murine model of breast cancer.
Torres-Alamilla P; Castillo-Sanchez R; Cortes-Reynosa P; Gomez R; Perez Salazar E
Mol Cell Endocrinol; 2023 Sep; 575():111998. PubMed ID: 37414130
[TBL] [Abstract][Full Text] [Related]
19. Estrogen regulates Hippo signaling via GPER in breast cancer.
Zhou X; Wang S; Wang Z; Feng X; Liu P; Lv XB; Li F; Yu FX; Sun Y; Yuan H; Zhu H; Xiong Y; Lei QY; Guan KL
J Clin Invest; 2015 May; 125(5):2123-35. PubMed ID: 25893606
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of PI3K/AKT molecular pathway mediated by membrane estrogen receptor GPER accounts for cryptotanshinone induced antiproliferative effect on breast cancer SKBR-3 cells.
Shi D; Zhao P; Cui L; Li H; Sun L; Niu J; Chen M
BMC Pharmacol Toxicol; 2020 May; 21(1):32. PubMed ID: 32357920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]